Campo, Elias
Article History
Accepted: 6 October 2023
First Online: 13 November 2023
Declarations
:
: E. Campo declares that he has no competing interests related to the content of this article. E. Campo has received honoraria for educational and consulting activities from GenMab, Takeda, Bristol Myers Squib, EUSA Pharma, Janssen and Roche. E. Campo has received research support from AstraZeneca and he is an author in two patents licensed to naoString and Diagnostica longwood.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
: The supplement containing this article is not sponsored by industry.